 | • レポートコード：MRC2312MG06044 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、75ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品 |
| Single User | ￥455,000 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥682,500 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界のグリメピリド散剤市場規模と予測を収録しています。・世界のグリメピリド散剤市場：売上、2018年-2023年、2024年-2029年 ・世界のグリメピリド散剤市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界のグリメピリド散剤市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「1mg」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 グリメピリド散剤のグローバル主要企業は、Sanofi、 CSPC、 JIANGSU WANBANG BIOPHARMACEUTICALS、 Wuhan Wei'ao Pharmaceutical Co.,Ltd.、 Beijing Beilu Pharmaceutical Co.,Ltd.、 Shandong Xinhua Pharmaceutical Company Limited、 Guizhou Tianan Pharmaceutical Co.,Ltd.などです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、グリメピリド散剤のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界のグリメピリド散剤市場：タイプ別、2018年-2023年、2024年-2029年 世界のグリメピリド散剤市場：タイプ別市場シェア、2022年 ・1mg、2mg 世界のグリメピリド散剤市場：用途別、2018年-2023年、2024年-2029年 世界のグリメピリド散剤市場：用途別市場シェア、2022年 ・病院、薬局 世界のグリメピリド散剤市場：地域・国別、2018年-2023年、2024年-2029年 世界のグリメピリド散剤市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業におけるグリメピリド散剤のグローバル売上、2018年-2023年 ・主要企業におけるグリメピリド散剤のグローバル売上シェア、2022年 ・主要企業におけるグリメピリド散剤のグローバル販売量、2018年-2023年 ・主要企業におけるグリメピリド散剤のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Sanofi、 CSPC、 JIANGSU WANBANG BIOPHARMACEUTICALS、 Wuhan Wei'ao Pharmaceutical Co.,Ltd.、 Beijing Beilu Pharmaceutical Co.,Ltd.、 Shandong Xinhua Pharmaceutical Company Limited、 Guizhou Tianan Pharmaceutical Co.,Ltd. ************************************************************* ・調査・分析レポートの概要 グリメピリド散剤市場の定義 市場セグメント 世界のグリメピリド散剤市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界のグリメピリド散剤市場規模 世界のグリメピリド散剤市場規模：2022年 VS 2029年 世界のグリメピリド散剤市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでのグリメピリド散剤の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業のグリメピリド散剤製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：1mg、2mg グリメピリド散剤のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：病院、薬局 グリメピリド散剤の用途別グローバル売上・予測 ・地域別市場分析 地域別グリメピリド散剤市場規模 2022年と2029年 地域別グリメピリド散剤売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Sanofi、 CSPC、 JIANGSU WANBANG BIOPHARMACEUTICALS、 Wuhan Wei'ao Pharmaceutical Co.,Ltd.、 Beijing Beilu Pharmaceutical Co.,Ltd.、 Shandong Xinhua Pharmaceutical Company Limited、 Guizhou Tianan Pharmaceutical Co.,Ltd. ... |
This research report provides a comprehensive analysis of the Glimepiride Dispersible Tablet market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Glimepiride Dispersible Tablet market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Glimepiride Dispersible Tablet, challenges faced by the industry, and potential opportunities for market players.
The global Glimepiride Dispersible Tablet market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Glimepiride Dispersible Tablet market presents opportunities for various stakeholders, including Hospital, Pharmacy. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Glimepiride Dispersible Tablet market. Additionally, the growing consumer demand present avenues for market expansion.
The global Glimepiride Dispersible Tablet market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the Glimepiride Dispersible Tablet market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Glimepiride Dispersible Tablet market.
Market Overview: The report provides a comprehensive overview of the Glimepiride Dispersible Tablet market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., 1mg, 2mg), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Glimepiride Dispersible Tablet market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Glimepiride Dispersible Tablet market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Glimepiride Dispersible Tablet market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Glimepiride Dispersible Tablet market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Glimepiride Dispersible Tablet market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Glimepiride Dispersible Tablet market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Glimepiride Dispersible Tablet, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Glimepiride Dispersible Tablet market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Glimepiride Dispersible Tablet market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
1mg
2mg
Market segment by Application
Hospital
Pharmacy
Global Glimepiride Dispersible Tablet Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Sanofi
CSPC
JIANGSU WANBANG BIOPHARMACEUTICALS
Wuhan Wei’ao Pharmaceutical Co.,Ltd.
Beijing Beilu Pharmaceutical Co.,Ltd.
Shandong Xinhua Pharmaceutical Company Limited
Guizhou Tianan Pharmaceutical Co.,Ltd.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Glimepiride Dispersible Tablet, market overview.
Chapter 2: Global Glimepiride Dispersible Tablet market size in revenue and volume.
Chapter 3: Detailed analysis of Glimepiride Dispersible Tablet manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Glimepiride Dispersible Tablet in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Glimepiride Dispersible Tablet capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Glimepiride Dispersible Tablet Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Glimepiride Dispersible Tablet Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Glimepiride Dispersible Tablet Overall Market Size
2.1 Global Glimepiride Dispersible Tablet Market Size: 2022 VS 2029
2.2 Global Glimepiride Dispersible Tablet Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Glimepiride Dispersible Tablet Sales: 2018-2029
3 Company Landscape
3.1 Top Glimepiride Dispersible Tablet Players in Global Market
3.2 Top Global Glimepiride Dispersible Tablet Companies Ranked by Revenue
3.3 Global Glimepiride Dispersible Tablet Revenue by Companies
3.4 Global Glimepiride Dispersible Tablet Sales by Companies
3.5 Global Glimepiride Dispersible Tablet Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Glimepiride Dispersible Tablet Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Glimepiride Dispersible Tablet Product Type
3.8 Tier 1, Tier 2 and Tier 3 Glimepiride Dispersible Tablet Players in Global Market
3.8.1 List of Global Tier 1 Glimepiride Dispersible Tablet Companies
3.8.2 List of Global Tier 2 and Tier 3 Glimepiride Dispersible Tablet Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Glimepiride Dispersible Tablet Market Size Markets, 2022 & 2029
4.1.2 1mg
4.1.3 2mg
4.2 By Type – Global Glimepiride Dispersible Tablet Revenue & Forecasts
4.2.1 By Type – Global Glimepiride Dispersible Tablet Revenue, 2018-2023
4.2.2 By Type – Global Glimepiride Dispersible Tablet Revenue, 2024-2029
4.2.3 By Type – Global Glimepiride Dispersible Tablet Revenue Market Share, 2018-2029
4.3 By Type – Global Glimepiride Dispersible Tablet Sales & Forecasts
4.3.1 By Type – Global Glimepiride Dispersible Tablet Sales, 2018-2023
4.3.2 By Type – Global Glimepiride Dispersible Tablet Sales, 2024-2029
4.3.3 By Type – Global Glimepiride Dispersible Tablet Sales Market Share, 2018-2029
4.4 By Type – Global Glimepiride Dispersible Tablet Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Glimepiride Dispersible Tablet Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Pharmacy
5.2 By Application – Global Glimepiride Dispersible Tablet Revenue & Forecasts
5.2.1 By Application – Global Glimepiride Dispersible Tablet Revenue, 2018-2023
5.2.2 By Application – Global Glimepiride Dispersible Tablet Revenue, 2024-2029
5.2.3 By Application – Global Glimepiride Dispersible Tablet Revenue Market Share, 2018-2029
5.3 By Application – Global Glimepiride Dispersible Tablet Sales & Forecasts
5.3.1 By Application – Global Glimepiride Dispersible Tablet Sales, 2018-2023
5.3.2 By Application – Global Glimepiride Dispersible Tablet Sales, 2024-2029
5.3.3 By Application – Global Glimepiride Dispersible Tablet Sales Market Share, 2018-2029
5.4 By Application – Global Glimepiride Dispersible Tablet Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Glimepiride Dispersible Tablet Market Size, 2022 & 2029
6.2 By Region – Global Glimepiride Dispersible Tablet Revenue & Forecasts
6.2.1 By Region – Global Glimepiride Dispersible Tablet Revenue, 2018-2023
6.2.2 By Region – Global Glimepiride Dispersible Tablet Revenue, 2024-2029
6.2.3 By Region – Global Glimepiride Dispersible Tablet Revenue Market Share, 2018-2029
6.3 By Region – Global Glimepiride Dispersible Tablet Sales & Forecasts
6.3.1 By Region – Global Glimepiride Dispersible Tablet Sales, 2018-2023
6.3.2 By Region – Global Glimepiride Dispersible Tablet Sales, 2024-2029
6.3.3 By Region – Global Glimepiride Dispersible Tablet Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Glimepiride Dispersible Tablet Revenue, 2018-2029
6.4.2 By Country – North America Glimepiride Dispersible Tablet Sales, 2018-2029
6.4.3 US Glimepiride Dispersible Tablet Market Size, 2018-2029
6.4.4 Canada Glimepiride Dispersible Tablet Market Size, 2018-2029
6.4.5 Mexico Glimepiride Dispersible Tablet Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Glimepiride Dispersible Tablet Revenue, 2018-2029
6.5.2 By Country – Europe Glimepiride Dispersible Tablet Sales, 2018-2029
6.5.3 Germany Glimepiride Dispersible Tablet Market Size, 2018-2029
6.5.4 France Glimepiride Dispersible Tablet Market Size, 2018-2029
6.5.5 U.K. Glimepiride Dispersible Tablet Market Size, 2018-2029
6.5.6 Italy Glimepiride Dispersible Tablet Market Size, 2018-2029
6.5.7 Russia Glimepiride Dispersible Tablet Market Size, 2018-2029
6.5.8 Nordic Countries Glimepiride Dispersible Tablet Market Size, 2018-2029
6.5.9 Benelux Glimepiride Dispersible Tablet Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Glimepiride Dispersible Tablet Revenue, 2018-2029
6.6.2 By Region – Asia Glimepiride Dispersible Tablet Sales, 2018-2029
6.6.3 China Glimepiride Dispersible Tablet Market Size, 2018-2029
6.6.4 Japan Glimepiride Dispersible Tablet Market Size, 2018-2029
6.6.5 South Korea Glimepiride Dispersible Tablet Market Size, 2018-2029
6.6.6 Southeast Asia Glimepiride Dispersible Tablet Market Size, 2018-2029
6.6.7 India Glimepiride Dispersible Tablet Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Glimepiride Dispersible Tablet Revenue, 2018-2029
6.7.2 By Country – South America Glimepiride Dispersible Tablet Sales, 2018-2029
6.7.3 Brazil Glimepiride Dispersible Tablet Market Size, 2018-2029
6.7.4 Argentina Glimepiride Dispersible Tablet Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Glimepiride Dispersible Tablet Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Glimepiride Dispersible Tablet Sales, 2018-2029
6.8.3 Turkey Glimepiride Dispersible Tablet Market Size, 2018-2029
6.8.4 Israel Glimepiride Dispersible Tablet Market Size, 2018-2029
6.8.5 Saudi Arabia Glimepiride Dispersible Tablet Market Size, 2018-2029
6.8.6 UAE Glimepiride Dispersible Tablet Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Sanofi
7.1.1 Sanofi Company Summary
7.1.2 Sanofi Business Overview
7.1.3 Sanofi Glimepiride Dispersible Tablet Major Product Offerings
7.1.4 Sanofi Glimepiride Dispersible Tablet Sales and Revenue in Global (2018-2023)
7.1.5 Sanofi Key News & Latest Developments
7.2 CSPC
7.2.1 CSPC Company Summary
7.2.2 CSPC Business Overview
7.2.3 CSPC Glimepiride Dispersible Tablet Major Product Offerings
7.2.4 CSPC Glimepiride Dispersible Tablet Sales and Revenue in Global (2018-2023)
7.2.5 CSPC Key News & Latest Developments
7.3 JIANGSU WANBANG BIOPHARMACEUTICALS
7.3.1 JIANGSU WANBANG BIOPHARMACEUTICALS Company Summary
7.3.2 JIANGSU WANBANG BIOPHARMACEUTICALS Business Overview
7.3.3 JIANGSU WANBANG BIOPHARMACEUTICALS Glimepiride Dispersible Tablet Major Product Offerings
7.3.4 JIANGSU WANBANG BIOPHARMACEUTICALS Glimepiride Dispersible Tablet Sales and Revenue in Global (2018-2023)
7.3.5 JIANGSU WANBANG BIOPHARMACEUTICALS Key News & Latest Developments
7.4 Wuhan Wei’ao Pharmaceutical Co.,Ltd.
7.4.1 Wuhan Wei’ao Pharmaceutical Co.,Ltd. Company Summary
7.4.2 Wuhan Wei’ao Pharmaceutical Co.,Ltd. Business Overview
7.4.3 Wuhan Wei’ao Pharmaceutical Co.,Ltd. Glimepiride Dispersible Tablet Major Product Offerings
7.4.4 Wuhan Wei’ao Pharmaceutical Co.,Ltd. Glimepiride Dispersible Tablet Sales and Revenue in Global (2018-2023)
7.4.5 Wuhan Wei’ao Pharmaceutical Co.,Ltd. Key News & Latest Developments
7.5 Beijing Beilu Pharmaceutical Co.,Ltd.
7.5.1 Beijing Beilu Pharmaceutical Co.,Ltd. Company Summary
7.5.2 Beijing Beilu Pharmaceutical Co.,Ltd. Business Overview
7.5.3 Beijing Beilu Pharmaceutical Co.,Ltd. Glimepiride Dispersible Tablet Major Product Offerings
7.5.4 Beijing Beilu Pharmaceutical Co.,Ltd. Glimepiride Dispersible Tablet Sales and Revenue in Global (2018-2023)
7.5.5 Beijing Beilu Pharmaceutical Co.,Ltd. Key News & Latest Developments
7.6 Shandong Xinhua Pharmaceutical Company Limited
7.6.1 Shandong Xinhua Pharmaceutical Company Limited Company Summary
7.6.2 Shandong Xinhua Pharmaceutical Company Limited Business Overview
7.6.3 Shandong Xinhua Pharmaceutical Company Limited Glimepiride Dispersible Tablet Major Product Offerings
7.6.4 Shandong Xinhua Pharmaceutical Company Limited Glimepiride Dispersible Tablet Sales and Revenue in Global (2018-2023)
7.6.5 Shandong Xinhua Pharmaceutical Company Limited Key News & Latest Developments
7.7 Guizhou Tianan Pharmaceutical Co.,Ltd.
7.7.1 Guizhou Tianan Pharmaceutical Co.,Ltd. Company Summary
7.7.2 Guizhou Tianan Pharmaceutical Co.,Ltd. Business Overview
7.7.3 Guizhou Tianan Pharmaceutical Co.,Ltd. Glimepiride Dispersible Tablet Major Product Offerings
7.7.4 Guizhou Tianan Pharmaceutical Co.,Ltd. Glimepiride Dispersible Tablet Sales and Revenue in Global (2018-2023)
7.7.5 Guizhou Tianan Pharmaceutical Co.,Ltd. Key News & Latest Developments
8 Global Glimepiride Dispersible Tablet Production Capacity, Analysis
8.1 Global Glimepiride Dispersible Tablet Production Capacity, 2018-2029
8.2 Glimepiride Dispersible Tablet Production Capacity of Key Manufacturers in Global Market
8.3 Global Glimepiride Dispersible Tablet Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Glimepiride Dispersible Tablet Supply Chain Analysis
10.1 Glimepiride Dispersible Tablet Industry Value Chain
10.2 Glimepiride Dispersible Tablet Upstream Market
10.3 Glimepiride Dispersible Tablet Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Glimepiride Dispersible Tablet Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer